Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.17 USD | +1.51% | +1.09% | -18.12% |
Financials (USD)
Sales 2024 * | 316M | Sales 2025 * | 418M | Capitalization | 1.14B |
---|---|---|---|---|---|
Net income 2024 * | -58M | Net income 2025 * | 18M | EV / Sales 2024 * | 2.7 x |
Net cash position 2024 * | 280M | Net cash position 2025 * | 360M | EV / Sales 2025 * | 1.86 x |
P/E ratio 2024 * |
-21.3
x | P/E ratio 2025 * |
65.8
x | Employees | 264 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.87% |
Latest transcript on Mirum Pharmaceuticals, Inc.
1 day | +1.51% | ||
1 week | +1.09% | ||
Current month | -3.78% | ||
1 month | -7.50% | ||
3 months | -8.62% | ||
6 months | -16.37% | ||
Current year | -18.12% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 45 | 18-05-06 | |
Michael Grey
FOU | Founder | 71 | 18-05-06 |
Peter Radovich
PSD | President | 46 | 20-04-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Walbert
BRD | Director/Board Member | 57 | 23-04-04 |
Michael Grey
FOU | Founder | 71 | 18-05-06 |
Patrick Heron
BRD | Director/Board Member | 53 | 18-11-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 24.17 | +1.51% | 254,735 |
24-04-19 | 23.81 | +1.02% | 336,931 |
24-04-18 | 23.57 | -1.17% | 400,347 |
24-04-17 | 23.85 | -0.67% | 327,457 |
24-04-16 | 24.01 | +0.42% | 317,919 |
Delayed Quote Nasdaq, April 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.12% | 1.14B | |
-0.02% | 42.11B | |
+48.66% | 40.08B | |
+5.04% | 40B | |
-11.32% | 26.87B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B |
- Stock Market
- Equities
- MIRM Stock